221 related articles for article (PubMed ID: 23375049)
1. Activity cliffs: facts or artifacts?
Medina-Franco JL
Chem Biol Drug Des; 2013 May; 81(5):553-6. PubMed ID: 23375049
[TBL] [Abstract][Full Text] [Related]
2. From activity cliffs to activity ridges: informative data structures for SAR analysis.
Vogt M; Huang Y; Bajorath J
J Chem Inf Model; 2011 Aug; 51(8):1848-56. PubMed ID: 21761918
[TBL] [Abstract][Full Text] [Related]
3. Structural interpretation of activity cliffs revealed by systematic analysis of structure-activity relationships in analog series.
Sisay MT; Peltason L; Bajorath J
J Chem Inf Model; 2009 Oct; 49(10):2179-89. PubMed ID: 19761254
[TBL] [Abstract][Full Text] [Related]
4. Extending the activity cliff concept: structural categorization of activity cliffs and systematic identification of different types of cliffs in the ChEMBL database.
Hu Y; Bajorath J
J Chem Inf Model; 2012 Jul; 52(7):1806-11. PubMed ID: 22758389
[TBL] [Abstract][Full Text] [Related]
5. Molecular scaffolds with high propensity to form multi-target activity cliffs.
Hu Y; Bajorath J
J Chem Inf Model; 2010 Apr; 50(4):500-10. PubMed ID: 20361784
[TBL] [Abstract][Full Text] [Related]
6. Prediction of individual compounds forming activity cliffs using emerging chemical patterns.
Namasivayam V; Iyer P; Bajorath J
J Chem Inf Model; 2013 Dec; 53(12):3131-9. PubMed ID: 24304008
[TBL] [Abstract][Full Text] [Related]
7. Searching for coordinated activity cliffs using particle swarm optimization.
Namasivayam V; Bajorath J
J Chem Inf Model; 2012 Apr; 52(4):927-34. PubMed ID: 22404190
[TBL] [Abstract][Full Text] [Related]
8. Do medicinal chemists learn from activity cliffs? A systematic evaluation of cliff progression in evolving compound data sets.
Dimova D; Heikamp K; Stumpfe D; Bajorath J
J Med Chem; 2013 Apr; 56(8):3339-45. PubMed ID: 23527828
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of single- and multi-target activity cliffs formed by currently available bioactive compounds.
Wassermann AM; Dimova D; Bajorath J
Chem Biol Drug Des; 2011 Aug; 78(2):224-8. PubMed ID: 21624090
[TBL] [Abstract][Full Text] [Related]
10. Exploring SAR continuity in the vicinity of activity cliffs.
Namasivayam V; Iyer P; Bajorath J
Chem Biol Drug Des; 2012 Jan; 79(1):22-9. PubMed ID: 21985661
[TBL] [Abstract][Full Text] [Related]
11. Activity cliffs in drug discovery: Dr Jekyll or Mr Hyde?
Cruz-Monteagudo M; Medina-Franco JL; Pérez-Castillo Y; Nicolotti O; Cordeiro MN; Borges F
Drug Discov Today; 2014 Aug; 19(8):1069-80. PubMed ID: 24560935
[TBL] [Abstract][Full Text] [Related]
12. Exploration of 3D activity cliffs on the basis of compound binding modes and comparison of 2D and 3D cliffs.
Hu Y; Bajorath J
J Chem Inf Model; 2012 Mar; 52(3):670-7. PubMed ID: 22394306
[TBL] [Abstract][Full Text] [Related]
13. Prediction of activity cliffs using support vector machines.
Heikamp K; Hu X; Yan A; Bajorath J
J Chem Inf Model; 2012 Sep; 52(9):2354-65. PubMed ID: 22894655
[TBL] [Abstract][Full Text] [Related]
14. MMP-Cliffs: systematic identification of activity cliffs on the basis of matched molecular pairs.
Hu X; Hu Y; Vogt M; Stumpfe D; Bajorath J
J Chem Inf Model; 2012 May; 52(5):1138-45. PubMed ID: 22489665
[TBL] [Abstract][Full Text] [Related]
15. From activity cliffs to target-specific scoring models and pharmacophore hypotheses.
Seebeck B; Wagener M; Rarey M
ChemMedChem; 2011 Sep; 6(9):1630-9, 1533. PubMed ID: 21751401
[TBL] [Abstract][Full Text] [Related]
16. Modeling of activity landscapes for drug discovery.
Bajorath J
Expert Opin Drug Discov; 2012 Jun; 7(6):463-73. PubMed ID: 22475223
[TBL] [Abstract][Full Text] [Related]
17. Recent progress in understanding activity cliffs and their utility in medicinal chemistry.
Stumpfe D; Hu Y; Dimova D; Bajorath J
J Med Chem; 2014 Jan; 57(1):18-28. PubMed ID: 23981118
[TBL] [Abstract][Full Text] [Related]
18. Method for the evaluation of structure-activity relationship information associated with coordinated activity cliffs.
Dimova D; Stumpfe D; Bajorath J
J Med Chem; 2014 Aug; 57(15):6553-63. PubMed ID: 25014781
[TBL] [Abstract][Full Text] [Related]
19. From structure-activity to structure-selectivity relationships: quantitative assessment, selectivity cliffs, and key compounds.
Peltason L; Hu Y; Bajorath J
ChemMedChem; 2009 Nov; 4(11):1864-73. PubMed ID: 19750525
[TBL] [Abstract][Full Text] [Related]
20. Single R-Group Polymorphisms (SRPs) and R-cliffs: an intuitive framework for analyzing and visualizing activity cliffs in a single analog series.
Agrafiotis DK; Wiener JJ; Skalkin A; Kolpak J
J Chem Inf Model; 2011 May; 51(5):1122-31. PubMed ID: 21504183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
